Physician profile
Ki M Hassler
NPI 1417027665
$5,567.27
in general payments reported to CMS, 2019-2025
10 companies · $870 in 2025
The $870 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $430 · 2020: $383 · 2021: $538 · 2022: $1,786 · 2023: $1,171 · 2024: $390 · 2025: $870.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,429 · Travel and Lodging: $1.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,428.76 |
| Travel and Lodging | $1.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $4,031.56 | 2019-2025 | Biomonitor, Amvia Edge, Acticor 7 Vr-T Dx |
| W. L. Gore & Associates, INC. | $614.55 | 2019-2023 | Gore Excluder Iliac Branch Endoprosthesis |
| Cvrx, INC. | $256.53 | 2022-2023 | Barostim Neo System |
| Silk Road Medical, INC. | $167.70 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $145.16 | 2019-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $142.59 | 2021-2023 | Xarelto |
| Abbott Laboratories | $116.97 | 2019-2025 | Jot Dx |
| Boston Scientific Corporation | $48.21 | 2019-2020 | |
| Medicomp INC | $29.84 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ki Hassler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.